These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 18805575

  • 1. Synchronous occult cancers of the endometrium and fallopian tube in an MSH2 mutation carrier at time of prophylactic surgery.
    Palma L, Marcus V, Gilbert L, Chong G, Foulkes WD.
    Gynecol Oncol; 2008 Dec; 111(3):575-8. PubMed ID: 18805575
    [Abstract] [Full Text] [Related]

  • 2. Occult cancer of the fallopian tube in a BRCA2 germline mutation carrier at prophylactic salpingo-oophorectomy.
    McEwen AR, McConnell DT, Kenwright DN, Gaskell DJ, Cherry A, Kidd AM.
    Gynecol Oncol; 2004 Mar; 92(3):992-4. PubMed ID: 14984974
    [Abstract] [Full Text] [Related]

  • 3. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.
    Paley PJ, Swisher EM, Garcia RL, Agoff SN, Greer BE, Peters KL, Goff BA.
    Gynecol Oncol; 2001 Feb; 80(2):176-80. PubMed ID: 11161856
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Salvador S, Rempel A, Soslow RA, Gilks B, Huntsman D, Miller D.
    Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations.
    Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek CJ.
    Am J Surg Pathol; 2009 Jan; 33(1):111-9. PubMed ID: 18830124
    [Abstract] [Full Text] [Related]

  • 9. Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation.
    Stuckless S, Green J, Dawson L, Barrett B, Woods MO, Dicks E, Parfrey PS.
    Clin Genet; 2013 Apr; 83(4):359-64. PubMed ID: 22775459
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Occult ovarian cancer at the time of risk-reducing salpingo-oophorectomy.
    Powell CB.
    Gynecol Oncol; 2006 Jan; 100(1):1-2. PubMed ID: 16368438
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.